The role of high-dose-rate brachytherapy boost in breast-conserving therapy: Long-term results of the Hungarian National Institute of Oncology

Reports of Practical Oncology and Radiotherapy

Volumn 15, Issue 1, 2010, Pages 1-7

  Polgár, Csaba ^a   Jánváry, Levente ^b   Major, Tibor ^a   Somogyi, András ^a   Takácsi Nagy, Zoltán ^a   Fröhlich, Georgina ^a   Fodor, János ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Boost; Breast conserving therapy; High dose rate brachytherapy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COBALT TELETHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROSIS; HUMAN; HUNGARY; OVERALL SURVIVAL; PHOTON THERAPY; RADIATION DOSE; RADIATION RESPONSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; TELANGIECTASIA; UNIVARIATE ANALYSIS;

EID: 77549083225     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2010.01.002     Document Type: Article

References (36)

1. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
3. NIH Consensus Conference: treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
4. Polgár C., Fodor J., Major T., Orosz Z., and Németh G. The role of boost irradiation in the conservative treatment of stage I-II breast cancer. Pathol Oncol Res 7 (2001) 241-250
5. Bartelink H., Horiot J.C., Poortmans H., Struikmans H., Van den Bogaert W., Fourquet A., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
6. Polgár C., Fodor J., Orosz Z., Major T., Takácsi-Nagy Z., Mangel L.C., et al. Electron and high dose rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: first results of the randomized Budapest boost trial. Strahlenther Onkol 178 (2002) 615-623
7. Polgár C., Fodor J., Orosz Z., Major T., Sulyok Z., Takácsi-Nagy Z., et al. Electron and brachytherapy boost in the conservative treatment of stage I-II breast cancer: 5-year results of the randomized Budapest boost trial. Radiother Oncol 64 Suppl. 1 (2002) S15
8. Romestaing P., Lehingue Y., Carrie C., Coquard R., Montbarbon X., Ardiet J.M., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15 (1997) 963-968
9. Fourquet A., Campana F., Mosseri V., Cetingoz R., Luciani S., Labib A., et al. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. Radiother Oncol 34 (1995) 114-120
10. Mansfield C.M., Komarnicky L.T., Schwartz G.F., Rosenberg A.L., Krishnan L., Jewell W.R., et al. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 75 (1995) 2328-2336
11. Perez C.A., Taylor M.E., Halverson K., Garcia D., Kuske R.R., and Lockett M.A. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison. Int J Radiat Oncol Biol Phys 34 (1996) 995-1007
12. Polgár C., and Major T. Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol 14 (2009) 7-24
13. Touboul E., Belkacemi Y., Lefranc J.P., Uzan S., Ozsahin M., Korbas D., et al. Early breast cancer: influence of type of boost (electron vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 34 (1995) 105-113
14. Vicini F.A., Horwitz E.M., Lacerna M.D., Dmuchowski C.F., Brown D.M., White J., et al. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 37 (1997) 845-852
15. Wazer D.E., Kramer B., Schmid C., Ruthazer R., Kramer B., Safaii H., et al. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys 39 (1997) 381-393
16. Henriquez I., Guix B., Tello J.I., Martinez A., Lejarcegui J.A., and Finestres F. Long term results of high-dose-rate (HDR) brachytherapy boost in preserving-breast cancer patients: the experience of Radiation Oncology Medical Institute (IMOR) of Barcelona. Radiother Oncol 60 Suppl. 1 (2001) S11
17. Resch A., Pötter R., Van Limbergen E., Biber E., Klein T., Fellner C., et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/PDR) for T1/T2 breast cancer. Radiother Oncol 63 (2002) 47-58
18. Neumanova R., Petera J., Frgala T., Dusek L., Jarkovsky J., and Kuricka R. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer. Neoplasma 54 (2008) 413-423
19. Hammer J., Seewald D.H., Track C., Zoidl J.P., and Labeck W. Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology 193 (1994) 573-577
20. Jacobs H. HDR afterloading experience in breast conservation therapy. Select Brachytherapy J 6 (1992) 14-17
21. Budrukkar A.N., Sarin R., Shrivastava S.K., Deshpande D.D., and Dinshaw K.A. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy. Clin Oncol 19 (2007) 596-603
22. Fijuth J. Brachytherapy in breast cancer. J Contemp Brachyther 1 (2009) 117-120
23. Guinot J.L., Roldan S., Maronas M., Tortajada I., Carrascosa M., Chust M.L., et al. Breast-conservative surgery with close or positive margins: can the breast be preserved with high-dose-rate brachytherapy boost?. Int J Radiat Oncol Biol Phys 68 (2007) 1381-1387
24. Hennequin C., Durdux C., Espié M., Balla-Mekias S., Housset M., Marty M., et al. High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys 45 (1999) 85-90
25. Knauerhase H., Strietzel M., Gerber B., Reimer T., and Fietkau R. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results. Int J Radiat Oncol Biol Phys 72 (2008) 1048-1055
26. Kubaszewska M., Dymnicka M., Skowronek J., Chichel A., and Kanikowski M. CT-image based conformal high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer-introducing the procedure. Rep Pract Oncol Radiother 13 (2008) 227-239
27. Manning M.A., Arthur D.W., Schmidt-Ullrich R.K., Arnfield M.R., Amir C., and Zwicker R.D. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme. Int J Radiat Oncol Biol Phys 48 (2000) 1301-1306
28. Joiner M.C. Linear-quadratic approach to fractionation. In: Steel G.G. (Ed). Basic clinical radiobiology (1993), Arnold, London 55-64
29. Zulewski J., and Liu E.T. The 1998 St. Gallen's Consensus Conference: an assessment. J Natl Cancer Inst 90 (1998) 1587-1589
30. Harris J., Levine M., Svensson G., and Hellman S. Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 5 (1979) 257-261
31. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
32. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
33. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
34. Van Limbergen E. Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer. Cancer Radiother 7 (2007) 107-120
35. Poortmans P., Bartelink H., Horiot J.C., Struikmans H., Van den Bogaert W., Fourquet A., et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC boost versus no boost randomised trial. Radiother Oncol 72 (2004) 25-33
36. Poortmans P., Bartelink H., Horiot J.C., Struikmans H., Van den Bogaert W., Fourquet A., et al. The influence of the boost technique on local control and fibrosis after breast conserving treatment: results of the EORTC. Radiother Oncol 88 Suppl. 2 (2008) S102